Quantcast
January 7, 2019 - PRWirePro

Neuronetics Announces Preliminary Fourth Quarter and Full Year Revenue

Malvern, PA, January 7, 2019 –(PRWirePro.com)– Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced certain unaudited preliminary fourth quarter and full year 2018 revenue. Preliminary fourth quarter Read more…